OBSERVATION OF THE TREATMENT EFFECTS OF ACIPIMOX ON HYPERLIPEMIA IN MON-INSULIN       DEPENDENT DIABETES MELLITUS PATIENTS

您当前的位置：

首页 >

文章列表页 >

OBSERVATION OF THE TREATMENT EFFECTS OF ACIPIMOX ON HYPERLIPEMIA IN MON-INSULIN DEPENDENT DIABETES MELLITUS PATIENTS

更新时间：2024-01-17

- OBSERVATION OF THE TREATMENT EFFECTS OF ACIPIMOX ON HYPERLIPEMIA IN MON-INSULIN DEPENDENT DIABETES MELLITUS PATIENTS
- Journal of Chongqing Medical University Issue 4, (1995)
- 作者机构：
  
  中国工程物理研究院科学城医院内科
- 作者简介：
- 基金信息：
- DOI：
  CLC： R587.1
- Published：1995，
扫描看全文
[1]王海燕,李佐强.乐脂平治疗非胰岛素依赖型糖尿病（NIDDM）患者高脂血症疗效观察[J].重庆医科大学学报,1995(04):289-291.

OBSERVATION OF THE TREATMENT EFFECTS OF ACIPIMOX ON HYPERLIPEMIA IN MON-INSULIN DEPENDENT DIABETES MELLITUS PATIENTS. [J]. Journal of Chongqing Medical University (4).(1995)
[1]王海燕,李佐强.乐脂平治疗非胰岛素依赖型糖尿病（NIDDM）患者高脂血症疗效观察[J].重庆医科大学学报,1995(04):289-291. DOI：

OBSERVATION OF THE TREATMENT EFFECTS OF ACIPIMOX ON HYPERLIPEMIA IN MON-INSULIN DEPENDENT DIABETES MELLITUS PATIENTS. [J]. Journal of Chongqing Medical University (4).(1995) DOI：

摘要

通过对乐脂平治疗１２例ＮＩＤＤＭ患者高脂血症的疗效观察，发现用药２周后，与治疗前相比较，ＨＤＬ－Ｃ水平明显增高，而ＬＤＬ－Ｃ与致冠心病独立因子ＬＰ（ａ）水平却显著降低，但对肝肾功能等均无不良影响，说明该药是治疗糖尿病高脂血症及防止糖尿病血管病变的有效药物。

Abstract

he Treatment effects of aclpimox on hyperlipemia in 12 type Ⅱ diabetic patients wore investi-gated in this paper.Comparing with the levels of serum lipid before treatment with aeipimox

thelevels of High Density Lipoprotein Cholesterol(HDL-C)were significantly increased

while the levelsof Low Density Lipoprotein cholesterol(LDL-C) and the independent factor causing coronary heartdi.ease[Lp(a)]were significantly reduced after administration of this drug for two weeks. Further-more

the hepatic and renal functions were not influenced by this drug It is indicated that acipimoxwas a potentially efficient drug to reduce serum lipid levels and prevent from macroangiopathy in di- abetes mellitus.

关键词

糖尿病高脂血症乐脂平

Keywords

diabetes mellitusHyperlipemiaAcipimox

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Protection of sodium glucose cotransporter-2 inhibitors on diabetic nephropathy

Research progress of ghrelin and diabetes mellitus

Research progress of a new anti-diabetic agent:SGLT2 inhibitors

Protective effect and mechanism of palmatine on diabetic mouse aorta

GLYCOSYLATED SERUM PROTEIN IN DIABETES MELLITUS

Related Author

Hu Yumei

Xia Jiajia

Ren Wei

Liang Huimin

Deng Huacong

Xiong Xin

Long Min

Cai Leiqin

Related Institution

Department of Endocrinology,The First Affiliated Hospital of Chongqing Medical University

Department of Endocrinology,Xinqiao Hospital,Third Military Medical University

Central Laboratory,Xinqiao Hospital,Third Military Medical University

Daping Hospital,Third Military Medical University

Department of Traditional Chinese Medicine,Xinqiao Hospital,Third Military Medical University

⁰